: : Takeda inks deal with Hutchmed for up to .1 billion #FinanceUSA #StockMarketNEWS Takeda Pharmaceutical Co. Ltd. TAKJP:4502 said Monday that it will acquire Hutchmed’s HCMHK:13 experimental cancer
@stockMarketNEWS Tue 24 Jan, 2023
: Takeda inks deal with Hutchmed for up to .1 billion #FinanceUSA #StockMarketNEWS
Takeda Pharmaceutical Co. Ltd. TAKJP:4502 said Monday that it will acquire Hutchmed’s HCMHK:13 experimental cancer treatment outside mainland China, Hong Kong and Macau, with plans to develop and commercialize fruquintinib. Per the terms of the deal, Takeda will make an upfront payment to Hutchmed for 0 million, with up to 0 million in potential milestone and royalty payments. The drug, fruquintinib, is approved in China as a treatment for refractory metastatic colorectal cancer. It is currently under review at the Food and Drug Administration. U.S.-listed shares of Takeda are up about 11% over the past year, while the S&P 500 SPX has declined 9.7%.
Munafa USA Munafa India Munafa NSE
More posts by @stockMarketNEWS
: U.S. stocks open modestly higher ahead of data on leading economic indicators #FinanceUSA #StockMarketNEWS U.S. stocks opened modestly higher Monday as investors await fresh economic data due out later
@stockMarketNEWS Tue 24 Jan, 2023
: : Pitney Bowes’ acknowledges activist investors attempt to change board control, stock rallies #FinanceUSA #StockMarketNEWS Shares of Pitney Bowes Inc. PBI rallied 4.8% in morning trading Monday,
@stockMarketNEWS Tue 24 Jan, 2023
0 Comments
Sorted by latest first Latest Oldest Best